Keratinocytes, which activate an EMT-like program in the skin, can prevent melanoma invasion, highlighting how changes in the tumor microenvironment can act as restraining forces in cancer.
When a patient needs a stem cell transplant, finding a registered donor is only the first step. Some potential donors drop out before confirmatory typing, reducing the pool from which doctors can ...
Dissecting protective versus detrimental immune responses uncovers biomarkers and mechanisms that can inform the rational design and evaluation of live attenuated vaccines against African swine fever ...
A mild oxalic-acid-based hydrometallurgical process enables efficient indium recovery from indium tin oxide in solar cell waste while simultaneously releasing silver grids. The approach achieves ...
Candel Therapeutics (CADL) shifts to late-stage oncology with CAN-2409 Phase III wins and BLA catalyst. Read here for a ...
Protein is one of the most talked-about nutrients in sport. It is also one of the easiest to oversimplify. On one side, there ...
Morning Overview on MSN
The FDA approved a first-of-its-kind cell therapy for blood-cancer transplant patients
Adults with blood cancers who receive stem cell transplants from matched donors now have a new defense against one of the ...
The Tranexamic Acid to Reduce Transfusion in Major Noncardiac Surgery(TRACTION) trial tested a hospital policy of routine tranexamic acid administration.
Quantified preferences favored higher lesion growth rate reduction (10%→50% at 18 months) as the primary driver across all ...
Not for distribution to United States newswire services or for dissemination in the United States. VANCOUVER, BC / ACCESS Newswire / June 29, 2026 / Nano One® Materials Corp. ("Nano One" ...
There's lots to like about Motorola's middle-child foldable — but how quickly will it feel outdated?
TRIDENT is a global, open-label, two-arm trial; secondary end points include progression-free survival, overall radiologic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results